In recent Rheumatoid November news:
- EMA accepts submission of Pfizer’s new arthritis drug— November 21, 2011: The European Medical Association has accepted Pfizer’s latest autoimmune arthritis drug tofacitinib for review in patients with moderate to severe rheumatoid arthritis. A new drug to compete with other biologics? Click to read more. New options are always a plus.
- Rheumatoid Arthritis Patients Say Treatment Lacks Goals…— A recent American College of Rheumatology survey suggests that more than half of RA patients in the states and in Western Europe feel treatment lacks goals, guidelines, and their disease is not “managed intensively.” No surprise here. Read more to learn about the rest of the survey.
- Medication and post-op flares— "We need to think a little bit more about how we hold them to optimize how patients do after surgery." an article discussing the implications of medicating prior to surgery and how the right timing of medication could lead to less pre-op flares. That would be nice.
- How Unchecked Alarms Can Spark Autoimmune Disease— November 28, 2011: "Cornell researchers have identified a signaling mechanism in immune-system cells that may contribute to this mistake, opening the door for possible new therapies for autoimmune diseases such as lupus and arthritis." Interesting new research for the autoimmune trigger. And by alarms they do not mean literal alarms (i.e: smoke alarms). This is a great read for those of you interest in what is going on with your body on a cellular level.
- Slow-to-Heal Wounds Linked to Autoimmune Disease— November 15, 2011: "Those with RA or Lupus are at risk;" New research has solidified what many of us already know— we heal slower when we’re sick. Click to read more about a new 10-year study by the National Institutes of Health (NIH) of healing with autoimmune disease(s) and what that means for us patients.
Blog of the week: Endo Emu. Like Chronicillness Cat? Have Endometriosis or pelvic pain? Hopefully you’ll enjoy this meme just as much!